 | Up a level |
2017
Rusakiewicz, Sylvie, Perier, Aurelie, Semeraro, Michaela, Pitt, Jonathan M., von Strandmann, Elke Pogge, Reiners, Katrin S., Aspeslagh, Sandrine, Piperoglou, Christelle, Vely, Frederic, Ivagnes, Alexandre, Jegou, Sarah, Halama, Niels, Chaigneau, Loic, Validire, Pierre, Christidis, Christos, Perniceni, Thierry, Landi, Bruno, Berger, Anne, Isambert, Nicolas, Domont, Julien, Bonvalot, Sylvie, Terrier, Philippe, Adam, Julien, Coindre, Jean-Michel, Emile, Jean-Francois, Poirier-Colame, Vichnou, Chaba, Kariman, Rocha, Benedita, Caignard, Anne 
ORCID: 0000-0001-9923-6045, Toubert, Antoine, Enot, David, Koch, Joachim, Marabelle, Aurelien, Lambert, Marion, Caillat-Zucman, Sophie ORCID: 0000-0002-4535-3550, Leyvraz, Serge, Auclair, Christian, Vivier, Eric ORCID: 0000-0001-7022-8287, Eggermont, Alexander, Borg, Christophe, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Le Cesne, Axel, Mir, Olivier ORCID: 0000-0002-6761-4002 and Zitvogel, Laurence
(2017).
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.
OncoImmunology, 6 (1).
PHILADELPHIA:
TAYLOR & FRANCIS INC.
ISSN 2162-402X
2014
Lartigue, Lydia, Lagarde, Pauline, Brulard, Celine, Neuville, Agnes, Rutkowski, Piotr, Dei Tos, Paolo, Waldermann, Eva, Debiec-Rychter, Maria, Italiano, Antoine, Coindre, Jean-Michel and Chibon, Frederic (2014). Genomic index is a strong predictor of metastatic outcome in intermediate gastrointestinal stromal tumors and an inclusion criteria for imatinib adjuvant therapy. Cancer Res., 74 (19). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445